Efficacy of New Measures Saving Time in Acute Stroke Management: A Quantified Analysis

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1817-1823. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.015. Epub 2017 May 15.

Abstract

Background: Time to treatment remains the most important factor in acute ischemic stroke prognosis. We quantified the effect of new interventions reducing in-hospital delays in acute stroke management and assessed its repercussion on door-to-imaging (DTI), imaging-to-needle (ITN), and door-to-needle (DTN) times.

Methods: Prospective registry of consecutive stroke patients who were candidates for reperfusion therapy attended in a tertiary care hospital from February 1 to December 31, 2014. A series of measures aimed at reducing in-hospital delays were implemented. We compared DTI, ITN, and DTN times between patients who underwent the interventions and those who did not.

Results: 231 patients. DTI time was lower when personal history was reviewed and tests were ordered before patient arrival (2.5 minutes saved, P = .016) and when electrocardiogram was not made (5.4 minutes saved, P < .001). Not performing a computed tomography angiography and not waiting for coagulation results from laboratory before intravenous thrombolysis (25.5%) reduced ITN time significantly (14 and 12 minutes saved, respectively, P < .001). These interventions remained as independent predictors of a shorter ITN and DTN time. Completing all steps resulted in the lowest DTI and ITN times (13 and 19 minutes, respectively).

Conclusions: Every measure is an important part of a chain focused on saving time in acute stroke: the lowest DTI and ITN times were obtained when all steps were completed. Measures shortening ITN time produced a greater impact on DTN time reduction; therefore, ITN interventions should be considered a critical part of new protocols and guidelines.

Keywords: Door-to-needle time; door-to-imaging; imaging-to-needle; intravenous thrombolysis; ischemic stroke treatment.

Publication types

  • Observational Study

MeSH terms

  • Administration, Intravenous
  • Aged
  • Aged, 80 and over
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / physiopathology
  • Brain Ischemia / therapy*
  • Cerebral Angiography / methods
  • Computed Tomography Angiography
  • Critical Pathways / organization & administration*
  • Delivery of Health Care, Integrated / organization & administration*
  • Efficiency, Organizational
  • Electrocardiography
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Models, Organizational
  • Patient Care Team / organization & administration
  • Process Assessment, Health Care / organization & administration*
  • Registries
  • Stroke / diagnostic imaging
  • Stroke / physiopathology
  • Stroke / therapy*
  • Tertiary Care Centers
  • Thrombolytic Therapy*
  • Time Factors
  • Time and Motion Studies
  • Time-to-Treatment / organization & administration*
  • Treatment Outcome
  • Workflow*

Substances

  • Fibrinolytic Agents